Fracture risk is increased in Crohn's disease, but not in ulcerative colitis

P Vestergaard1, K Krogh, L Rejnmark

  • 1The Osteoporosis Clinic, Aarhus Amtssygehus, Aarhus University Hospital, Denmark.

Gut
|January 22, 2000
PubMed

Insights

Female patients with Crohn's disease have a higher risk of low-energy fractures. This study investigated fracture rates and risk factors in inflammatory bowel disease patients, finding a significant association primarily in women with Crohn's disease.

Area of Science:

  • Gastroenterology
  • Rheumatology
  • Epidemiology

Background:

  • Inflammatory bowel disease (IBD), encompassing Crohn's disease (CD) and ulcerative colitis (UC), is associated with various extraintestinal manifestations.
  • Fracture risk is a recognized complication in IBD, but specific risk factors and differences between CD and UC require further elucidation.

Purpose of the Study:

  • To investigate and compare fracture incidence and associated risk factors in patients diagnosed with Crohn's disease and ulcerative colitis.
  • To identify patient demographics and disease-specific factors contributing to increased fracture risk in IBD.

Main Methods:

  • A cross-sectional study utilizing self-administered questionnaires distributed to members of the Danish Colitis/Crohn Association and randomly selected controls.
  • Analysis included 817 IBD patients (383 CD, 434 UC) and 635 controls, comparing fracture rates and risk factors between groups.

Main Results:

  • Female patients with Crohn's disease exhibited a significantly increased risk of fractures (RR=2.5), particularly low-energy fractures of the spine, ribs, pelvis, feet, and toes.
  • No increased fracture risk was observed in male Crohn's disease patients or in patients with ulcerative colitis.
  • Increased fracture risk in Crohn's disease correlated with the duration of systemic corticosteroid use.

Conclusions:

  • Female patients with Crohn's disease face an elevated risk of low-energy fractures, a risk not observed in male CD patients or UC patients.
  • Systemic corticosteroid use is a significant risk factor for fractures in Crohn's disease patients.
  • These findings highlight the need for targeted fracture prevention strategies in specific IBD patient populations.
Abstract

Related Concept Videos

Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
1.5K
Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
1.6K
Inflammatory Bowel Disease I: Introduction01:26

Inflammatory Bowel Disease I: Introduction

Inflammatory bowel disease is a group of chronic disorders marked by recurrent inflammation of the gastrointestinal tract due to an abnormal immune response against gut microflora. This leads to tissue damage. The two main forms are Crohn’s disease and ulcerative colitis.Crohn’s DiseaseCrohn’s disease is a relapsing inflammatory disorder that can affect any part of the GI tract, from the mouth to the anus. It involves all layers of the bowel wall (transmural) and shows...
79
Inflammatory Bowel Disease II: Ulcerative Colitis01:20

Inflammatory Bowel Disease II: Ulcerative Colitis

Ulcerative colitis is a chronic inflammatory disorder of the colon characterized by continuous mucosal inflammation that typically begins in the rectum and extends proximally in a uniform pattern. Its pathogenesis involves a complex interplay of genetic predisposition, immune dysregulation, and environmental influences. These factors converge to impair the colon’s epithelial defenses and promote an exaggerated inflammatory response against luminal contents.Breakdown of the Mucosal...
57
Inflammatory Bowel Disease III: Crohn's Disease01:25

Inflammatory Bowel Disease III: Crohn's Disease

Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
69
Inflammatory Bowel Disease IV: Clinical Manifestations01:20

Inflammatory Bowel Disease IV: Clinical Manifestations

Inflammatory bowel disease (IBD) encompasses two major chronic disorders—ulcerative colitis and Crohn’s disease—each characterized by relapsing episodes of gastrointestinal inflammation. Although they share certain clinical features, their patterns of involvement and manifestations differ in ways that aid diagnosis and guide management.Ulcerative ColitisUlcerative colitis is limited to the colon and rectum and involves continuous inflammation of the mucosal layer. The...
64